DekaBank Deutsche Girozentrale
ANAB icon

DekaBank Deutsche Girozentrale’s AnaptysBio ANAB Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,300
Closed -$107K – 1373
2022
Q2 		$107K Hold
5,300
– – ﹤0.01% 1274
2022
Q1 		$130K Buy
5,300
+500
+10% +$15.1K ﹤0.01% 1254
2021
Q4 		$168K Buy
4,800
+100
+2% +$3.17K ﹤0.01% 1292
2021
Q3 		$124K Hold
4,700
– – ﹤0.01% 1279
2021
Q2 		$119K Hold
4,700
– – ﹤0.01% 1307
2021
Q1 		$94K Hold
4,700
– – ﹤0.01% 1285
2020
Q4 		$100K Hold
4,700
– – ﹤0.01% 1274
2020
Q3 		$67K Buy
+4,700
New +$84.8K ﹤0.01% 1159

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ANAB Position: Q3 2022 in Review

DekaBank Deutsche Girozentrale sold out of AnaptysBio (ANAB) in Q3 2022, closing a stake of 5,300 shares — an estimated $107K sold.

DekaBank Deutsche Girozentrale first reported a position in ANAB in Q3 2020 and held it in 8 quarters. The position peaked at $168K in Q4 2021. 114 funds tracked by Wall St. Rank hold ANAB as of Q3 2022.

  • DekaBank Deutsche Girozentrale reported no remaining AnaptysBio position as of Q3 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 5,300 AnaptysBio shares in Q3 2022, an estimated $107K.
  • DekaBank Deutsche Girozentrale first reported a position in AnaptysBio in Q3 2020 and held it in 8 quarters.
  • DekaBank Deutsche Girozentrale's AnaptysBio position peaked at $168K in Q4 2021.
  • 114 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2022, filed 2 Nov 2022.